Precigen Stock Today
| PGEN Stock | USD 1.80 0.06 3.45% |
PerformanceSolid
| Odds Of DistressLow
|
Precigen is selling at 1.80 as of the 16th of March 2025; that is 3.45 percent increase since the beginning of the trading day. The stock's open price was 1.74. Precigen has only a 6 % chance of going through financial distress over the next few years and had a solid performance during the last 90 days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 8th of August 2013 | Category Healthcare | Classification Health Care |
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland. Precigen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 292.87 M outstanding shares of which 19.05 M shares are at this time shorted by private and institutional investors with about 9.69 trading days to cover. More on Precigen
Moving together with Precigen Stock
Moving against Precigen Stock
Precigen Stock Highlights
| CEO President | Helen MPH | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsPrecigen can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Precigen's financial leverage. It provides some insight into what part of Precigen's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Precigen (PGEN) is traded on NASDAQ Exchange in USA. It is located in 20358 Seneca Meadows Parkway, Germantown, MD, United States, 20876 and employs 202 people. Precigen is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 527.16 M. Precigen conducts business under Biotechnology sector and is part of Health Care industry. The entity has 292.87 M outstanding shares of which 19.05 M shares are at this time shorted by private and institutional investors with about 9.69 trading days to cover.
Precigen currently holds about 115.3 M in cash with (66.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.55.
Check Precigen Probability Of Bankruptcy
Ownership AllocationPrecigen owns a total of 292.87 Million outstanding shares. Over half of Precigen's outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Precigen Ownership Details
Precigen Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Jpmorgan Chase & Co | 2024-12-31 | 845.2 K | |
| Susquehanna International Group, Llp | 2024-12-31 | 704.9 K | |
| Lexaurum Advisors, Llc | 2024-12-31 | 691.5 K | |
| Gmt Capital Corp | 2024-12-31 | 668.8 K | |
| Ci Private Wealth Llc | 2024-12-31 | 614 K | |
| Nuveen Asset Management, Llc | 2024-12-31 | 535 K | |
| Goldman Sachs Group Inc | 2024-12-31 | 507.5 K | |
| Clarivest Asset Management Llc | 2024-09-30 | 492.2 K | |
| D. E. Shaw & Co Lp | 2024-12-31 | 424.9 K | |
| Patients Capital Management Llc | 2024-12-31 | 17.9 M | |
| Adage Capital Partners Gp Llc | 2024-12-31 | 10.9 M |
Precigen Historical Income Statement
Precigen Stock Against Markets
Precigen Corporate Management
| Rob Russell | VP Resources | Profile | |
| Mr JD | Chief Secretary | Profile | |
| Donald Lehr | Chief Secretary | Profile | |
| Rutul Shah | Chief Officer | Profile | |
| Jeffrey Perez | Senior Affairs | Profile | |
| Jeffrey JD | Senior Affairs | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precigen. If investors know Precigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precigen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.54) | Revenue Per Share | Quarterly Revenue Growth (0.31) | Return On Assets | Return On Equity |
The market value of Precigen is measured differently than its book value, which is the value of Precigen that is recorded on the company's balance sheet. Investors also form their own opinion of Precigen's value that differs from its market value or its book value, called intrinsic value, which is Precigen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precigen's market value can be influenced by many factors that don't directly affect Precigen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precigen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Precigen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precigen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.